Radioembolization of liver metastases in patients with colorectal cancer: a nonsurgical treatment with combined modality potential.
Kuebler
J Philip
JP
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001918:Brachytherapy; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000556:secondary*; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000556:secondary; D020714:Maximum Tolerated Dose; D008863:Microspheres; D019275:Radiopharmaceuticals / Q000008:administration & dosage* / Q000009:adverse effects; D018714:Radiotherapy, Adjuvant; D013997:Time Factors; D059004:Topoisomerase I Inhibitors; D016896:Treatment Outcome; D015020:Yttrium Isotopes / Q000008:administration & dosage* / Q000009:adverse effects
D000964:Antimetabolites, Antineoplastic; D004791:Enzyme Inhibitors; D019275:Radiopharmaceuticals; D059004:Topoisomerase I Inhibitors; D015020:Yttrium Isotopes; D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin